Director at $CMI sells 1,810 shares in insider sale

In a recent insider sale, WILLIAM I MILLER, a director at $CMI, sold 1,810 shares of the company on 02-11-2026 amounting to an estimated $1,070,452. This sale represented approximately 3.8% of their shares of this class of stock, leaving them with a remaining ownership of 45,217 shares of this class of $CMI stock. The information on this transaction was obtained from a recent SEC filing.

Over the past 6 months, $CMI insiders have engaged in 26 trades on the open market. Among these transactions, there have been no purchases and 26 sales. Notable among these trades are those of MARK ANDREW SMITH, the VP – Chief Financial Officer, who conducted 11 sales, disposing of 30,390 shares for an estimated $13,549,420. WILLIAM I MILLER has made 9 sales, selling 18,107 shares for an estimated $10,811,645. JENNIFER RUMSEY, the Chair and CEO, also participated in 2 sales, selling 4,570 shares for an estimated $2,165,656. Other executives such as ROBERT ENRIGHT, BRETT MICHAEL MERRITT, and KAREN H QUINTOS were also involved in selling shares of $CMI stock.

Tracking insider transactions can provide valuable insight into the sentiments and actions of company insiders. For a comprehensive view of insider trading activities, interested parties can refer to Quiver Quantitative’s insider trading dashboard.

Moving to $CMI hedge fund activity, 822 institutional investors have added shares of $CMI stock to their portfolio, while 768 reduced their positions in the most recent quarter. Some of the notable recent movements include UBS AM, FMR LLC, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, PUBLIC INVESTMENT FUND, FIRST EAGLE INVESTMENT MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, and MORGAN STANLEY, each making significant adjustments to their holdings of $CMI stock.

In terms of revenue, $CMI reported revenues of $8.5B in Q4 2025, reflecting a 1.05% increase from the same period in the previous year. For a detailed analysis of CMI’s financial performance, interested parties can refer to Quiver Quantitative’s CMI stock page.

Members of Congress have also been actively trading $CMI stock, with 3 transactions taking place in the past 6 months. These trades consisted of 1 purchase and 2 sales. Notable among these trades is REPRESENTATIVE LISA C. MCCLAIN, who conducted 3 transactions involving $CMI stock.

Analysts on Wall Street have issued reports on $CMI in recent months, with 5 firms issuing buy ratings on the stock and 0 firms issuing sell ratings. Analysts from Citigroup, Truist Securities, Argus Research, Wells Fargo, and Melius Research have all provided favorable ratings and insights on $CMI.

Multiple analysts have also set price targets for $CMI in recent months, with a median target of $610.0. Notable analysts such as Tim Thein from Raymond James, Jamie Cook from Truist Securities, Jerry Revich from Wells Fargo, Adam Seiden from Barclays, Tami Zakaria from JP Morgan, Kyle Menges from Citigroup, and Steven Fisher from UBS have all offered their price targets and perspectives on $CMI.

It is important to note that the information in this article is not financial advice. Interested individuals should refer to Quiver Quantitative’s disclaimers for additional information. For comprehensive and up-to-date data on $CMI, including insider trading activities, hedge fund movements, revenue reports, congressional trading, analyst ratings, and price targets, interested parties can access Quiver Quantitative’s dedicated pages and dashboards for $CMI stock.